Takahiro Kodama

Scopus Author ID Scopus Author ID Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 46

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Hepatology (Baltimore, Md.)

Hepatology communications

Cancers

Osaka University

Osaka University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaka University Jun 01 2016

Japan

Assistant Professor :: Department of Gastroenterology and Hepatology

Houston Methodist Research Institute Jul 10 2012 - May 23 2016

United States

Postdoctoral associate :: Cancer biology

Education History

Osaka University

Japan

PHD :: Medicine

Publications

Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Takeshi Tomonaga, Naoya Sakamoto, Eiichi Morii, Tetsuo Takehara
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications 8 (6) (2024)
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Takeshi Tomonaga, Naoya Sakamoto, Eiichi Morii, Tetsuo Takehara
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications 8 (6) (2024)
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Takeshi Tomonaga, Naoya Sakamoto, Eiichi Morii, Tetsuo Takehara
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications 8 (6) (2024)
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Takeshi Tomonaga, Naoya Sakamoto, Eiichi Morii, Tetsuo Takehara
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications 8 (6) (2024)
Emi Sometani, Hayato Hikita, Kazuhiro Murai, Hidenori Toyoda, Satoshi Tanaka, Tsugiko Oze, Jihyun Sung, Akiyoshi Shimoda, Makoto Fukuoka, Satoshi Shigeno, Keisuke Fukutomi, Kumiko Shirai, Yuki Tahata, Yoshinobu Saito, Akira Nishio, Kunimaro Furuta, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Eiji Mita, Akihiro Umezawa, Yasuhito Tanaka, Tetsuo Takehara
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs. Hepatology research : the official journal of the Japan Society of Hepatology (2024)
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, Tomohide Tatsumi, Takeshi Tomonaga, Naoya Sakamoto, Eiichi Morii, Tetsuo Takehara
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD. Hepatology communications 8 (6) (2024)
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, Yuta Myojin, Akira Doi, Akira Nishio, Ryoko Yamada, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Taizo Hijioka, Mitsuru Sakakibara, Yoshinori Doi, Naruyasu Kakita, Takayuki Yakushijin, Ryotaro Sakamori, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers 15 (2) (2023)
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, Yuta Myojin, Akira Doi, Akira Nishio, Ryoko Yamada, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Taizo Hijioka, Mitsuru Sakakibara, Yoshinori Doi, Naruyasu Kakita, Takayuki Yakushijin, Ryotaro Sakamori, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers 15 (2) (2023)
Kazuhiro Murai, Hayato Hikita, Takahiro Kodama, Masaki Kaibori, Yuki Nishimura, Tomohide Tatsumi, Tomomi Yamada, Tatsuya Kanto, Satoshi Mochida, Tetsuo Takehara
The impact of the COVID-19 pandemic on hepatocellular carcinoma diagnosis and treatment in Japan - a multicenter collaborative observational study. Hepatology research : the official journal of the Japan Society of Hepatology (2023)
Takahiro Kodama, Tetsuo Takehara
Is it a prime time for germline genetic testing for HCC? Hepatology (Baltimore, Md.) (2023)
Takahiro Kodama, Tetsuo Takehara
Is it a prime time for germline genetic testing for HCC? Hepatology (Baltimore, Md.) (2023)
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, Yuta Myojin, Akira Doi, Akira Nishio, Ryoko Yamada, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Taizo Hijioka, Mitsuru Sakakibara, Yoshinori Doi, Naruyasu Kakita, Takayuki Yakushijin, Ryotaro Sakamori, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral. Cancers 15 (2) (2023)
Hiroki Murai, Takahiro Kodama, Tetsuo Takehara
Reply. Hepatology (Baltimore, Md.) 76 (6) (2022)
Hiroki Murai, Takahiro Kodama, Tetsuo Takehara
Reply. Hepatology (Baltimore, Md.) 76 (6) (2022)
Yuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, Akira Doi, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Masanori Miyazaki, Yasutoshi Nozaki, Akira Kaneko, Masahide Oshita, Satoshi Tanaka, Kazuho Imanaka, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Takayuki Yakushijin, Mitsuru Sakakibara, Sadaharu Iio, Yoshinori Doi, Tomohide Tatsumi, null And, Tetsuo Takehara
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Yuki Tahata, Ryotaro Sakamori, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Yasutoshi Nozaki, Masahide Oshita, Naoki Hiramatsu, Masanori Miyazaki, Eiji Mita, Keiji Yamamoto, Kazuyoshi Ohkawa, Akira Kaneko, Toshifumi Ito, Yoshinori Doi, Takayuki Yakushijin, Taizo Hijioka, Hiroyuki Fukui, Kazuho Imanaka, Yuichi Yoshida, Yukinori Yamada, Tomohide Tatsumi, Tetsuo Takehara
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis. Hepatology research : the official journal of the Japan Society of Hepatology 52 (10) (2022)
Takahiro Kodama, Michiko Kodama, Nancy A Jenkins, Neal G Copeland, Huanhuan Joyce Chen, Zhubo Wei
Ring Finger Protein 125 Is an Anti-Proliferative Tumor Suppressor in Hepatocellular Carcinoma. Cancers 14 (11) (2022)
Takahiro Kodama, Tetsuo Takehara
Reply. Hepatology (Baltimore, Md.) 75 (5) (2022)
Yuki Makino, Hayato Hikita, Kenji Fukumoto, Ji Hyun Sung, Yoshihiro Sakano, Kazuhiro Murai, Sadatsugu Sakane, Takahiro Kodama, Ryotaro Sakamori, Jumpei Kondo, Shogo Kobayashi, Tomohide Tatsumi, Tetsuo Takehara
Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis. Cancer research 82 (16) (2022)
Kazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasutoshi Nozaki, Kengo Matsumoto, Seiichi Tawara, Kazuto Fukuda, Yuichi Yoshida, Satoshi Tanaka, Toshifumi Ito, Yoshinori Doi, Sadaharu Iio, Mitsuru Sakakibara, Fumihiko Nakanishi, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration. Journal of gastroenterology and hepatology 37 (6) (2022)
Takayuki Matsumae, Takahiro Kodama, Yuta Myojin, Kazuki Maesaka, Ryotaro Sakamori, Ayako Takuwa, Keiko Oku, Daisuke Motooka, Yoshiyuki Sawai, Masahide Oshita, Tasuku Nakabori, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka, Eiji Mita, Seiichi Tawara, Takayuki Yakushijin, Yasutoshi Nozaki, Hideki Hagiwara, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy. Cancers 14 (14) (2022)
Yuki Tahata, Ryotaro Sakamori, Kazuki Maesaka, Akira Doi, Ryoko Yamada, Takahiro Kodama, Hayato Hikita, Masanori Miyazaki, Yasutoshi Nozaki, Akira Kaneko, Masahide Oshita, Satoshi Tanaka, Kazuho Imanaka, Naoki Hiramatsu, Naoki Morishita, Kazuyoshi Ohkawa, Takayuki Yakushijin, Mitsuru Sakakibara, Sadaharu Iio, Yoshinori Doi, Tomohide Tatsumi, Tetsuo Takehara
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Akira Doi, Yuki Tahata, Masanori Miyazaki, Kazuyoshi Ohkawa, Eiji Mita, Sadaharu Iio, Yasutoshi Nozaki, Takayuki Yakushijin, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 52 (7) (2022)
Kazuhiro Murai, Takahiro Kodama, Hayato Hikita, Akiyoshi Shimoda, Makoto Fukuoka, Keisuke Fukutomi, Satoshi Shigeno, Yuto Shiode, Daisuke Motooka, Yuichiro Higuchi, Kei Miyakawa, Hiroshi Suemizu, Akihide Ryo, Yuki Tahata, Yuki Makino, Ryoko Yamada, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapy. Hepatology communications 6 (9) (2022)
Yuto Shiode, Takahiro Kodama, Satoshi Shigeno, Kazuhiro Murai, Satoshi Tanaka, Justin Y Newberg, Jumpei Kondo, Shogo Kobayashi, Ryoko Yamada, Hayato Hikita, Ryotaro Sakamori, Hiroshi Suemizu, Tomohide Tatsumi, Hidetoshi Eguchi, Nancy A Jenkins, Neal G Copeland, Tetsuo Takehara
TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation. Hepatology (Baltimore, Md.) (2022)
Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka, Eiji Mita, Seiichi Tawara, Takayuki Yakushijin, Yasutoshi Nozaki, Hideki Hagiwara, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy. Cancers 14 (4) (2022)
Takahiro Kodama, Tetsuo Takehara
Reply. Hepatology (Baltimore, Md.) 75 (4) (2022)
Hiroki Murai, Takahiro Kodama, Kazuki Maesaka, Shoichiro Tange, Daisuke Motooka, Yutaka Suzuki, Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Yoshihiro Ono, Yu Takahashi, Yota Kawasaki, Satoshi Iino, Shogo Kobayashi, Masashi Idogawa, Takashi Tokino, Tomomi Hashidate-Yoshida, Hideo Shindou, Masanori Miyazaki, Yasuharu Imai, Satoshi Tanaka, Eiji Mita, Kazuyoshi Ohkawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Hidetoshi Eguchi, Eiichi Morii, Tetsuo Takehara
Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Eiji Mita, Toshifumi Ito, Hideki Hagiwara, Takayuki Yakushijin, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Hepatology research : the official journal of the Japan Society of Hepatology 52 (3) (2021)
Junki Hirano, Sachiyo Yoshio, Yusuke Sakai, Li Songling, Tatsuya Suzuki, Yumi Itoh, He Zhang, David Virya Chen, Saori Haga, Hiroko Oomori, Takahiro Kodama, Yusuke Maeda, Yoshihiro Ono, Yu Takahashi, Daron M Standley, Masahiro Yamamoto, Kohji Moriishi, Kyoji Moriya, Tatsuya Kanto, Tetsuo Takehara, Kazuhiko Koike, Yoshiharu Matsuura, Toru Okamoto
Hepatitis C virus modulates signal peptide peptidase to alter host protein processing. Proceedings of the National Academy of Sciences of the United States of America 118 (22) (2021)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Masahide Oshita, Hideki Hagiwara, Mitsuru Sakakibara, Shinji Tamura, Naoki Hiramatsu, Masami Inada, Sadaharu Iio, Toshifumi Ito, Takayuki Yakushijin, Yoshinori Doi, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment. Hepatology research : the official journal of the Japan Society of Hepatology 51 (5) (2021)
Makiko Urabe, Hayato Hikita, Yoshinobu Saito, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuta Myojin, Akira Doi, Katsuhiko Sato, Sadatsugu Sakane, Yuki Makino, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
Activation of p53 After Irradiation Impairs the Regenerative Capacity of the Mouse Liver. Hepatology communications (2021)
Kazuhiro Kozumi, Takahiro Kodama, Hiroki Murai, Sadatsugu Sakane, Olivier Govaere, Simon Cockell, Daisuke Motooka, Naruyasu Kakita, Yukinori Yamada, Yasuteru Kondo, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Ryotaro Sakamori, Yoshihiro Kamada, Ann K Daly, Quentin Mark Anstee, Tomohide Tatsumi, Eiichi Morii, Tetsuo Takehara
Transcriptomics Identify Thrombospondin-2 as a Biomarker for NASH and Advanced Liver Fibrosis. Hepatology (Baltimore, Md.) 74 (5) (2021)
Keisuke Fukutomi, Hayato Hikita, Kazuhiro Murai, Tasuku Nakabori, Akiyoshi Shimoda, Makoto Fukuoka, Takuo Yamai, Yuichiro Higuchi, Kei Miyakawa, Hiroshi Suemizu, Akihide Ryo, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
Capsid Allosteric Modulators Enhance the Innate Immune Response in Hepatitis B Virus-Infected Hepatocytes During Interferon Administration. Hepatology communications (2021)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Ayako Urabe, Yuki Tahata, Masahide Oshita, Kazuyoshi Ohkawa, Eiji Mita, Hideki Hagiwara, Shinji Tamura, Toshifumi Ito, Takayuki Yakushijin, Sadaharu Iio, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension. Hepatology research : the official journal of the Japan Society of Hepatology 50 (9) (2020)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Yasuharu Imai, Masahide Oshita, Kazuyoshi Ohkawa, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Initial treatment response to transarterial chemoembolization as a predictive factor for Child-Pugh class deterioration prior to refractoriness in hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 50 (11) (2020)
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Naoki Hiramatsu, Hideki Hagiwara, Masahide Oshita, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Clinical outcomes of direct-acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment. Hepatology research : the official journal of the Japan Society of Hepatology 50 (10) (2020)
Yuki Tahata, Ryotaro Sakamori, Ayako Urabe, Ryoko Yamada, Kazuyoshi Ohkawa, Naoki Hiramatsu, Hideki Hagiwara, Masahide Oshita, Taizo Hijioka, Shinji Tamura, Yasuharu Imai, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2020)
Kazuhiro Murai, Hayato Hikita, Yugo Kai, Yasuteru Kondo, Makoto Fukuoka, Keisuke Fukutomi, Akira Doi, Takuo Yamai, Tasuku Nakabori, Ryo Fukuda, Takeshi Takahashi, Kei Miyakawa, Hiroshi Suemizu, Akihide Ryo, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway. Scientific reports 10 (1) (2020)
Kazuki Maesaka, Ryotaro Sakamori, Ryoko Yamada, Yuki Tahata, Ayako Urabe, Minoru Shigekawa, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 50 (3) (2019)
Shinji Matsumoto, Taku Yamamichi, Koei Shinzawa, Yuuya Kasahara, Satoshi Nojima, Takahiro Kodama, Satoshi Obika, Tetsuo Takehara, Eiichi Morii, Hiroomi Okuyama, Akira Kikuchi
GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling. Nature communications 10 (1) (2019)
Shigeki Suemura, Takahiro Kodama, Yuta Myojin, Ryoko Yamada, Minoru Shigekawa, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma. Cancers 11 (9) (2019)
Takahiro Kodama, Teresa A Marian, Hubert Lee, Michiko Kodama, Jian Li, Michael S Parmacek, Nancy A Jenkins, Neal G Copeland, Zhubo Wei
MRTFB suppresses colorectal cancer development through regulating SPDL1 and MCAM. Proceedings of the National Academy of Sciences of the United States of America 116 (47) (2019)
Takahiro Kodama, Jing Yi, Justin Y Newberg, Jean C Tien, Hao Wu, Milton J Finegold, Michiko Kodama, Zhubo Wei, Takeshi Tamura, Tetsuo Takehara, Randy L Johnson, Nancy A Jenkins, Neal G Copeland
Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 115 (44) (2018)
Michiko Kodama, Takahiro Kodama, Justin Y Newberg, Hiroyuki Katayama, Makoto Kobayashi, Samir M Hanash, Kosuke Yoshihara, Zhubo Wei, Jean C Tien, Roberto Rangel, Kae Hashimoto, Seiji Mabuchi, Kenjiro Sawada, Tadashi Kimura, Neal G Copeland, Nancy A Jenkins
In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 114 (35) (2017)
Roberto Rangel, Song-Choon Lee, Kenneth Hon-Kim Ban, Liliana Guzman-Rojas, Michael B Mann, Justin Y Newberg, Takahiro Kodama, Leslie A McNoe, Luxmanan Selvanesan, Jerrold M Ward, Alistair G Rust, Kuan-Yew Chin, Michael A Black, Nancy A Jenkins, Neal G Copeland
Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America 113 (48) (2016)

Takahiro Kodama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Takahiro Kodama